Alpha Cognition (ACOG) Accounts Payables (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Accounts Payables of $9.0 million for Q4 2025, up 268.01% year-over-year from $2.4 million in Q4 2024, and up 37.49% quarter-over-quarter from $6.5 million in Q3 2025.
Alpha Cognition (ACOG) Accounts Payables (2023 - 2026) Analysis & Trends
Alpha Cognition's Accounts Payables history runs 3 years deep, the most recent figure standing at $9.0 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 268.01% year-over-year to $9.0 million; the TTM figure through Dec 2025 stood at $9.0 million (up 268.01% YoY), while the FY2025 annual figure was $9.0 million, up 268.01% from the prior year.
- Accounts Payables for Q4 2025 stood at $9.0 million, up from $6.5 million in the prior quarter.
- The five-year high for Accounts Payables was $9.0 million in Q4 2025, with the low at $790310.0 in Q3 2024.
- The 3-year median for Accounts Payables is $2.5 million (2024), against an average of $3.3 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables surged 74.97% in 2024, then jumped 726.13% in 2025.
- Alpha Cognition's Accounts Payables stood at $1.4 million in 2023, then surged by 74.97% to $2.4 million in 2024, then jumped by 268.01% to $9.0 million in 2025.
- Business Quant data shows ACOG's Accounts Payables at $9.0 million in Q4 2025, $6.5 million in Q3 2025, and $2.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | 6.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.24 Mn |
| Dec 31, 2025 | 8.98 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 2.57 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 790,310.00 |
| Jun 30, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.39 Mn |